Hennion & Walsh Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.4M | Buy |
|
|||||
|
2023
Q3 | $982K | Buy |
|
|||||
|
2023
Q2 | $768K | Sell |
|
|||||
|
2023
Q1 | $792K | Buy |
|
|||||
|
2022
Q4 | $895K | Buy |
|
|||||
|
2022
Q3 | $651K | Buy |
|
|||||
|
2022
Q2 | $470K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.5M | Sell |
|
|||||
|
2021
Q2 | $1.82M | Sell |
|
|||||
|
2021
Q1 | $4.35M | Buy |
|